Category: General Surgery

Neoadjuvant GOLP Improves Outcomes in High-Risk Cholangiocarcinoma

Neoadjuvant GOLP therapy significantly enhances event-free survival in patients with resectable high-risk intrahepatic cholangiocarcinoma. Median event-free survival was 18.0 months with GOLP, compared to 8.7 months in the control group (p<0.001). Overall survival at 24 months was 79% for the neoadjuvant group vs. 61% for controls (hazard ratio 0.43). Expect lower-grade adverse events overall, with […]

Global Surgery Progress Stalled: Alarming Indicator Gaps

Surgeons need to know that 39% of countries provide timely access to essential surgery, underscoring a significant global shortfall in surgical care. Only 50.3% of countries meet benchmarks for surgical workforce density. 31.5% of countries report adequate surgical volume, with no country-level benchmarks on perioperative mortality. Integrating standardized surgical metrics into health systems is essential […]

Effective Strategies for Malignant Gastric Outlet Obstruction

Endoscopic ultrasound-guided gastrojejunostomy (eus-gj) outperforms surgical methods for malignant gastric outlet obstruction, impacting patient outcomes. EUS-gj shows a clinical success rate significantly higher than surgical gastrojejunostomy (rr 0.82) and enteral stents (rr 0.91). Surgical options are linked to longer hospital stays and increased reintervention rates compared to EUS-gj. Consider recommending EUS-gj as the primary treatment […]

Neoadjuvant Chemotherapy Fails to Outperform Surgery in Colon Cancer

Neoadjuvant chemotherapy does not improve disease-free survival compared to upfront surgery for locally advanced colon cancer, but shows benefits in feasibility and reduced need for adjuvant therapy. Three-year disease-free survival: 87% for upfront surgery vs. 83% for neoadjuvant chemotherapy (p=0.36). Reduced requirement for adjuvant chemotherapy in the neoadjuvant group (59% vs 73%, p=0.02). Surgeons should […]

Medicaid Expansion Linked to Better Outcomes in Pancreatic Cancer

Medicaid expansion improves survival and surgical access for pancreatic cancer patients. Residents in states with early, on-time, and late Medicaid expansion had 2-year mortality reductions (hazard ratios ranging from 0.91 to 0.94). There was a 19% increase in the odds of surgical resection with Medicaid expansion (odds ratio 1.19). Outcomes improved primarily after three years […]

Long-Term Results of taTME for Rectal Cancer Confirm Efficacy

taTME shows promising long-term outcomes for low rectal cancer patients, crucial for surgical practice. Three-year overall survival was 93.7%, with disease-free survival at 84.6%. Late complications in 32 patients, with 21 classified as severe; one required surgical revision. Surgery can prioritize sphincter preservation without compromising oncologic outcomes. 97% of patients were stoma-free at three years, […]

Synthetic Mesh Lowers Parastomal Hernia Recurrence

Using synthetic mesh for parastomal hernia repair reduces long-term recurrence risk compared to biologic mesh, which is crucial for surgical decision-making. Parastomal hernia recurrence rate at 5 years was 33.6% overall (37.5% for biologic vs. 29.4% for synthetic). Synthetic mesh showed a 45% reduction in recurrence risk (HR=0.65, p=0.028). Consider using synthetic mesh for better […]

Liver Transplant After Immunotherapy Shows Strong Outcomes

Transplanting liver patients who respond to atezolizumab-bevacizumab is promising for those with intermediate and advanced hepatocellular carcinoma. Recurrence-free survival is 90% and overall survival is 94% at two years post-transplant. Acute rejection rates are 25%, but remain manageable; 62.5% had complications within 90 days of transplant. Surgical teams should consider immunotherapy response when selecting candidates […]

Video Analysis Reveals Key Non-Technical Skills in Surgery

Silent video can predict surgeons’ non-technical skills, impacting training and outcomes. Analyzed 40 laparoscopic appendectomy videos with over 10,000 annotated actions. Mean cognitive rating was 5.6 out of 8, with a correlation between decision-making and situation awareness (r=0.8). This method paves the way for scalable assessments of surgical performance. Five key predictive factors identified include […]

Surgeon performance in shared decision-making varies widely

This study assessed shared decision-making among thousands of surgeons, revealing critical insights for improving patient outcomes. Only 1.2% of surgeons achieved top scores in shared decision-making, while 64% of patients felt their surgeons performed adequately. Male surgeons, those in cardiothoracic specialties, and surgeons with over 31 years of practice were linked to lower decision-making scores. […]